{"id":"https://openalex.org/W4361908403","doi":"https://doi.org/10.1158/1078-0432.22449779.v1","title":"Supplementary Table 1 from A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP\u2013Rituximab versus CHOP + 131Iodine\u2014Tositumomab","display_name":"Supplementary Table 1 from A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP\u2013Rituximab versus CHOP + 131Iodine\u2014Tositumomab","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361908403","doi":"https://doi.org/10.1158/1078-0432.22449779.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22449779.v1","doi":"https://doi.org/10.1158/1078-0432.22449779.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22449779.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_A_Comparative_Analysis_of_Prognostic_Factor_Models_for_Follicular_Lymphoma_Based_on_a_Phase_III_Trial_of_CHOP_Rituximab_versus_CHOP_sup_131_sup_Iodine_Tositumomab/22449779/1/files/39900842.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_A_Comparative_Analysis_of_Prognostic_Factor_Models_for_Follicular_Lymphoma_Based_on_a_Phase_III_Trial_of_CHOP_Rituximab_versus_CHOP_sup_131_sup_Iodine_Tositumomab/22449779/1/files/39900842.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023180146","display_name":"Oliver W. Press","orcid":"https://orcid.org/0000-0002-3147-8037","observed_orcids":["https://orcid.org/0000-0002-3147-8037"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oliver W. Press","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091192260","display_name":"Joseph M. Unger","orcid":"https://orcid.org/0000-0002-5191-0317","observed_orcids":["https://orcid.org/0000-0002-5191-0317"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph M. Unger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014743270","display_name":"Lisa M. Rimsza","orcid":"https://orcid.org/0000-0003-1268-2750","observed_orcids":["https://orcid.org/0000-0003-1268-2750"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa M. Rimsza","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038526399","display_name":"Jonathan W. Friedberg","orcid":"https://orcid.org/0000-0002-1420-5563","observed_orcids":["https://orcid.org/0000-0002-1420-5563"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan W. Friedberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041539801","display_name":"Michael Leo LeBlanc","orcid":"https://orcid.org/0000-0001-7192-2860","observed_orcids":["https://orcid.org/0000-0001-7192-2860"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael LeBlanc","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110554446","display_name":"Myron Stefan Czuczman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Myron S. Czuczman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080366682","display_name":"Mark Stefan Kaminski","orcid":"https://orcid.org/0000-0002-8712-2953","observed_orcids":["https://orcid.org/0000-0002-8712-2953"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Kaminski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076637635","display_name":"Rita M. Braziel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rita M. Braziel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113605893","display_name":"Catherine M. Spier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catherine Spier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004025497","display_name":"Ajay K. Gopal","orcid":"https://orcid.org/0000-0003-3023-6834","observed_orcids":["https://orcid.org/0000-0003-3023-6834"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ajay K. Gopal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016684714","display_name":"David G. Maloney","orcid":"https://orcid.org/0000-0002-8477-6919","observed_orcids":["https://orcid.org/0000-0002-8477-6919"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David G. Maloney","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082606841","display_name":"Bruce D. Cheson","orcid":"https://orcid.org/0000-0001-9255-7655","observed_orcids":["https://orcid.org/0000-0001-9255-7655"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bruce D. Cheson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064449830","display_name":"Shaker R. Dakhil","orcid":"https://orcid.org/0000-0002-6261-5882","observed_orcids":["https://orcid.org/0000-0002-6261-5882"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shaker R. Dakhil","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102767715","display_name":"Thomas P. Miller","orcid":"https://orcid.org/0000-0002-7100-2682","observed_orcids":["https://orcid.org/0000-0002-7100-2682"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas P. Miller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111441938","display_name":"Richard I. Fisher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard I. Fisher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":1.0},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8949999809265137},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8289999961853027},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9990000128746033},{"id":"https://openalex.org/keywords/multivariable-models","display_name":"multivariable models","score":0.7770000100135803},{"id":"https://openalex.org/keywords/univariate-analysis","display_name":"univariate analysis","score":0.6710000038146973}],"concepts":[{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.8182067275047302},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.8129109740257263},{"id":"https://openalex.org/C2779725641","wikidata":"https://www.wikidata.org/wiki/Q1076228","display_name":"CHOP","level":3,"score":0.7357736825942993},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5466263294219971},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5403973460197449},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5301709175109863},{"id":"https://openalex.org/C187785154","wikidata":"https://www.wikidata.org/wiki/Q5464664","display_name":"Follicular phase","level":2,"score":0.5280131697654724},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.48990577459335327},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3795146942138672}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.22449779.v1","doi":"https://doi.org/10.1158/1078-0432.22449779.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22449779.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_A_Comparative_Analysis_of_Prognostic_Factor_Models_for_Follicular_Lymphoma_Based_on_a_Phase_III_Trial_of_CHOP_Rituximab_versus_CHOP_sup_131_sup_Iodine_Tositumomab/22449779/1/files/39900842.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22449779","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_1_from_A_Comparative_Analysis_of_Prognostic_Factor_Models_for_Follicular_Lymphoma_Based_on_a_Phase_III_Trial_of_CHOP_Rituximab_versus_CHOP_sup_131_sup_Iodine_Tositumomab/22449779","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22449779.v1","doi":"https://doi.org/10.1158/1078-0432.22449779.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22449779.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_1_from_A_Comparative_Analysis_of_Prognostic_Factor_Models_for_Follicular_Lymphoma_Based_on_a_Phase_III_Trial_of_CHOP_Rituximab_versus_CHOP_sup_131_sup_Iodine_Tositumomab/22449779/1/files/39900842.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361908403.pdf","grobid_xml":"https://content.openalex.org/works/W4361908403.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1970884884","https://openalex.org/W3022433164","https://openalex.org/W2051457079","https://openalex.org/W1972710872","https://openalex.org/W2980299611","https://openalex.org/W2408094891","https://openalex.org/W3001925272","https://openalex.org/W1982626297","https://openalex.org/W2980742945","https://openalex.org/W2164679264"],"abstract_inverted_index":{"PDF":[0],"file":[1],"54K,":[2],"Supplementary":[3],"Table":[4],"1:":[5],"Results":[6],"of":[7,10],"Multivariable":[8],"Model":[9],"All":[11],"Statistically":[12],"Significant":[13],"Factors":[14],"for":[15],"Both":[16],"PFS":[17],"and":[18],"OS":[19],"from":[20],"Univariate":[21],"Analyses":[22]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}